66
Views
0
CrossRef citations to date
0
Altmetric
Review

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency

, &
Pages 1-12 | Published online: 22 Dec 2009

References

  • FischerALeDFHacein-Bey-AbinaSSevere combined immunodeficiency. A model disease for molecular immunology and therapyImmunol Rev20052039810915661024
  • HershfieldMSMitchellBSImmunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiencyScriverCRBeaudetALSlyWSValleDThe Metabolic and Molecular Basis of Inherited DiseaseNew York, NYMcGraw-Hill199517251768
  • LeeNRussellNGaneshaguruKMechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminaseBr J Haematol19845611071196231047
  • ApasovSGBlackburnMRKellemsRESmithPTSitkovskyMVAdenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signalingJ Clin Invest2001108113114111435465
  • Gangi-PetersonLSorscherDHReynoldsJWKeplerTBMitchellBSNucleotide pool imbalance and adenosine deaminase deficiency induce alterations of N-region insertions during V(D)J recombinationJ Clin Invest1999103683384110079104
  • BenvenistePZhuWCohenAInterference with thymocyte differentiation by an inhibitor of S-adenosylhomocysteine hydrolaseJ Immunol199515525365447608534
  • HershfieldMSNew insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiencyEur J Immunol2005351253015580654
  • CassaniBMiroloMCattaneoFAltered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patientsBlood200811184209421918218852
  • BlackburnMRKellemsREAdenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammationAdv Immunol20058614115705418
  • BoothCHershfieldMNotarangeloLManagement options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006)Clin Immunol2007123213914717300989
  • HirschhornRRoegner-ManiscalcoVKuritskyLRosenFSBone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patientsJ Clin Invest1981686138713937033281
  • BoothCGasparHBPegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID)Biologics2009334935819707420
  • MortellaroAHernandezRJGuerriniMMEx vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defectsBlood200610892979298816835374
  • RogersMHLwinRFairbanksLGerritsenBGasparHBCognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiencyJ Pediatr20011391445011445793
  • HonigMAlbertMHSchulzAPatients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complicationsBlood200710983595360217185467
  • TitmanPPinkESkucekECognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficienciesBlood200811293907391318645040
  • GasparHBAiutiAPortaFCandottiFHershfieldMSNotarangeloLDHow I treat ADA deficiencyBlood2009114173524353219638621
  • ChanBWaraDBastianJLong-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)Clin Immunol2005117213314316112907
  • MalacarneFBenicchiTNotarangeloLDReduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patientsEur J Immunol200535113376338616276484
  • BollingerMEArredondo-VegaFXSantistebanISchwarzKHershfieldMSLedermanHMBrief report: hepatic dysfunction as a complication of adenosine deaminase deficiencyN Engl J Med199633421136713718614422
  • BlackburnMRAldrichMVolmerJBThe use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice. Differential impact on pulmonary and immunologic abnormalitiesJ Biol Chem200027541321143212110908569
  • HirschhornRImmunodeficiency due to adenosine deaminaseOchsHDSmithCIEPuckJMPrimary Immunodeficiency Diseases: A Molecular and Genetic ApproachNew York, NYOxford University Press Inc, USA1998
  • DaddonaPEMitchellBSMeuwissenHJDavidsonBLWilsonJMKollerCAAdenosine deaminase deficiency with normal immune function. An acidic enzyme mutationJ Clin Invest19837224834926603477
  • HirschhornRIn vivo reversion to normal of inherited mutations in humansJ Med Genet2003401072172814569115
  • WigintonDAAdrianGSFriedmanRLSuttleDPHuttonJJCloning of cDNA sequences of human adenosine deaminaseProc Natl Acad Sci U S A19838024748174856200875
  • ValerioDMcIvorRSWilliamsSRCloning of human adenosine deaminase cDNA and expression in mouse cellsGene1984311–31471536526272
  • DaddonaPEShewachDSKelleyWNArgosPMarkhamAFOrkinSHHuman adenosine deaminase. cDNA and complete primary amino acid sequenceJ Biol Chem19842591912101121066090454
  • GiblettERAndersonJECohenFPollaraBMeuwissenHJAdenosinedeaminase deficiency in two patients with severely impaired cellular immunityLancet197227786106710694117384
  • ValerioDDuyvesteynMGvan der EbAJIntroduction of sequences encoding functional human adenosine deaminase into mouse cells using a retroviral shuttle systemGene1985342–31631684007492
  • FriedmanRLExpression of human adenosine deaminase using a transmissable murine retrovirus vector systemProc Natl Acad Sci U S A19858237037073856223
  • KantoffPWKohnDBMitsuyaHCorrection of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transferProc Natl Acad Sci U S A19868317656365673489233
  • JoynerAKellerGPhillipsRABernsteinARetrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cellsNature198330559345565586312324
  • KellerGPaigeCGilboaEWagnerEFExpression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursorsNature198531860421491543903518
  • EglitisMAKantoffPGilboaEAndersonWFGene expression in mice after high efficiency retroviral-mediated gene transferScience19852304732139513982999985
  • BelmontJWHenkel-TiggesJChangSMExpression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transferNature198632260773853873016551
  • LimBApperleyJFOrkinSHWilliamsDALong-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cellsProc Natl Acad Sci U S A19898622889288962573068
  • WilsonJMDanosOGrossmanMRauletDHMulliganRCExpression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cellsProc Natl Acad Sci U S A19908714394432296599
  • KantoffPWGillioAPMcLachlinJRExpression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transferJ Exp Med198716612192343298525
  • BodineDMMcDonaghKTBrandtSJDevelopment of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cellsProc Natl Acad Sci U S A19908710373837422339117
  • vanBVKuklerAHeidtPJValerioDLong-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cellsProc Natl Acad Sci U S A19928916764076441502175
  • NoltaJAKohnDBComparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cellsHum Gene Ther1990132572682081193
  • DonahueREKesslerSWBodineDHelper virus induced T-cell lymphoma in nonhuman primates after retroviral mediated gene transferJ Exp Med19921764112511351383375
  • VaninEFKalossMBrosciusCNienhuisAWCharacterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesisJ Virol1994687424142508207799
  • FerrariGRossiniSGiavazziRAn in vivo model of somatic cell gene therapy for human severe combined immunodeficiencyScience19912514999136313661848369
  • CulverKWMorganRAOsborneWRIn vivo expression and survival of gene-modified T lymphocytes in rhesus monkeysHum Gene Ther1990143994101964096
  • BlaeseRMCulverKWMillerADT lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 yearsScience199527052354754807570001
  • OnoderaMArigaTKawamuraNSuccessful peripheral T-lymphocyte-directed gene transfer for a patient with severe combined immune deficiency caused by adenosine deaminase deficiencyBlood199891130369414266
  • BordignonCNotarangeloLDNobiliNGene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patientsScience199527052354704757570000
  • KohnDBWeinbergKINoltaJAEngraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiencyNat Med1995110101710237489356
  • HoogerbruggePMvanBVFischerABone marrow gene transfer in three patients with adenosine deaminase deficiencyGene Ther1996321791838867866
  • AiutiAVaiSMortellaroAImmune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacementNat Med20028542342511984564
  • BaumCMWeissmanILTsukamotoASBuckleAMPeaultBIsolation of a candidate human hematopoietic stem-cell populationProc Natl Acad Sci U S A1992897280428081372992
  • LuensKMTravisMAChenBPHillBLScollayRMurrayLJThrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu boneBlood1998914120612159454750
  • Cavazzana-CalvoMHacein-BeySde SaintBGGene therapy of human severe combined immunodeficiency (SCID)-X1 diseaseScience2000288546666967210784449
  • HanenbergHHashinoKKonishiHHockRAKatoIWilliamsDAOptimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cellsHum Gene Ther1997818219322069449373
  • AiutiASlavinSAkerMCorrection of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioningScience200229655772410241312089448
  • AiutiACattaneoFGalimbertiSGene therapy for immunodeficiency due to adenosine deaminase deficiencyN Engl J Med2009360544745819179314
  • AiutiACassaniBAndolfGMultilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapyJ Clin Invest200711782233224017671653
  • GasparHBBjorkegrenEParsleyKSuccessful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioningMol Ther200614450551316905365
  • Hacein-Bey-AbinaSGarrigueAWangGPInsertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1J Clin Invest200811893132314218688285
  • HoweSJMansourMRSchwarzwaelderKInsertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJ Clin Invest200811893143315018688286
  • WuXLiYCriseBBurgessSMTranscription start regions in the human genome are favored targets for MLV integrationScience200330056261749175112805549
  • MontiniECesanaDSchmidtMThe genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJ Clin Invest2009119496497519307726
  • CharrierSDupreLScaramuzzaSLentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patientsGene Ther200714541542817051251
  • ModlichUBohneJSchmidtMCell-culture assays reveal the importance of retroviral vector design for insertional genotoxicityBlood200610882545255316825499
  • ZychlinskiDSchambachAModlichUPhysiological Promoters reduce the genotoxic risk of integrating gene vectorsMol Ther200816471872518334985
  • MontiniECesanaDSchmidtMHematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integrationNat Biotechnol200624668769616732270
  • SchambachABohneJChandraSEqual potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cellsMol Ther200613239140016226060
  • ZhangFThornhillSIHoweSJLentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cellsBlood200711051448145717456723
  • StrachanTReadAPHuman Molecular Genetics 22nd edWilmington, DEWiley-Liss1999
  • GasznerMFelsenfeldGInsulators: exploiting transcriptional and epigenetic mechanismsNat Rev Genet20067970371316909129
  • ChungJHWhiteleyMFelsenfeldGA 5’ element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in DrosophilaCell19937435055148348617
  • ChungJHBellACFelsenfeldGCharacterization of the chicken beta-globin insulatorProc Natl Acad Sci U S A19979425755809012826
  • LiCLXiongDStamatoyannopoulosGEmeryDWGenomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulatorMol Ther200917471672419240697
  • RyuBYEvans-GaleaMVGrayJTBodineDMPersonsDANienhuisAWAn experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activationBlood200811141866187517991809
  • UrbinatiFArumugamPHigashimotoTMechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3’LTRMol Ther20091791527153619384292
  • RamezaniAHawleyTSHawleyRGStable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic developmentMol Ther200614224525416731046
  • RamezaniAHawleyTSHawleyRGCombinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5’HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potentialStem Cells200826123257326618787211
  • MitraKLenzJA combinatorial insulator approach confers effective protection against insertional activation of oncogenes in a stringent tumorigenesis modelMol Ther20092717(Suppl 1)S142
  • BokhovenMStephenSLKnightSInsertional gene activation by lentiviral and gammaretroviral vectorsJ Virol200983128329418945765